title: Completeness of case ascertainment at the Irish National Cancer Registry.
abstract: BACKGROUND
  Cancer registries play a major role in cancer control, including quantifying the burden of cancer in the population, informing health service planning, and evaluating service provision. Registries must achieve a high level of completeness of case ascertainment.
  
  
  OBJECTIVE
  Completeness of case ascertainment for the National Cancer Registry (NCR) in Ireland was estimated.
  
  
  METHODS
  For all invasive cancers, and the four most common sites, we used two quantitative methods which use information from death certificates to obtain estimates of completeness of registration-the Lincoln-Petersen (LP) estimator (which provides a lower bound estimate) and the flow method (which estimates completeness at a fixed time-point, in this case 5 years). Data were extracted at the end of 2010. Independent case ascertainment was used to assess completeness of breast cancer registration in the 50-64 age group and of rectal cancer in surgical patients diagnosed in 2007.
  
  
  RESULTS
  Completeness of case ascertainment was >99 % for the breast screening age-group and for surgical rectal cancer cases. A lower bound on completeness of case ascertainment for all invasive cancers excluding non-melanoma skin cancers is 94.3 % using the LP estimator. The estimate from the flow method is 97 % after 5 years, [95 % confidence interval (96.2 %, 97.7 %)]. Five-year levels of completeness for the four commonest cancers using the flow method were: colorectal, 97.4 %; lung, 98.7 %; prostate, 95.8 % and breast, 98.0 %.
  
  
  CONCLUSIONS
  The estimated levels of completeness for the NCR are satisfactory. Further work is required to compare the methods used.
authors: National Cancer Registry, Cork Airport Business Park, Cork, Ireland, k.obrien@ncri.ie.
authors: K
authors: K
authors: O'Brien
authors: H
authors: H
authors: Comber
authors: L
authors: L
authors: Sharp
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology*; D015179:Colorectal Neoplasms / Q000453:epidemiology; D016001:Confidence Intervals; D003644:Death Certificates; D005260:Female; D006801:Humans; D007494:Ireland / Q000453:epidemiology; D008175:Lung Neoplasms / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000453:epidemiology; D012004:Rectal Neoplasms / Q000453:epidemiology* / Q000601:surgery; D012042:Registries / Q000592:standards / Q000706:statistics & numerical data*; D013997:Time Factors
references: J Public Health (Oxf). 2007 Dec;29(4):455-62
references: 17827194
references: Br J Cancer. 2011 Jun 28;105(1):170-6
references: 21559016
references: Public Health. 1997 Sep;111(5):339-43
references: 9308385
references: Methods Inf Med. 2009;48(3):267-71
references: 19387506
references: Colorectal Dis. 2012 Oct;14(10):e692-700
references: 22731759
references: Eur J Cancer. 2013 Apr;49(6):1374-403
references: 23485231
references: Eur J Public Health. 2013 Oct;23(5):889-93
references: 23002230
references: Eur J Cancer. 2009 Apr;45(6):931-91
references: 19171476
references: Br J Cancer. 2005 Feb 14;92(3):576-9
references: 15655546
references: Eur J Cancer. 2009 May;45(7):1218-1231
references: 19091545
references: Lancet Oncol. 2005 Apr;6(4):193-5
references: 15811615
references: Biom J. 2008 Dec;50(6):1077-92
references: 19067337
references: Br J Cancer. 2000 Mar;82(5):1111-6
references: 10737395
references: Eur J Cancer. 2009 Mar;45(5):756-64
references: 19128954
references: Acta Oncol. 2012 Sep;51(7):880-9
references: 22974093
references: Eur J Cancer. 2009 Mar;45(5):747-55
references: 19117750